Systematic review of alternative HIV preexposure prophylaxis care delivery models to improve preexposure prophylaxis services.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
17
7
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
To identify types, evidence, and study gaps of alternative HIV preexposure prophylaxis (PrEP) care delivery models in the published literature. Systematic review and narrative synthesis. We searched in the US Centers for Disease Control and Prevention (CDC) Prevention Research Synthesis (PRS) database through December 2022 (PROSPERO CRD42022311747). We included studies published in English that reported implementation of alternative PrEP care delivery models. Two reviewers independently reviewed the full text and extracted data by using standard forms. Risk of bias was assessed using the adapted Newcastle-Ottawa Quality Assessment Scale. Those that met our study criteria were evaluated for efficacy against CDC Evidence-Based Intervention (EBI) or Evidence-Informed Intervention (EI) criteria or Health Resources and Services Administration Emergency Strategy (ES) criteria, or for applicability by using an assessment based on the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework. This review identified 16 studies published between 2018 and 2022 that implemented alternative prescriber ( n = 8), alternative setting for care ( n = 4), alternative setting for laboratory screening ( n = 1), or a combination of the above ( n = 3) . The majority of studies were US-based ( n = 12) with low risk of bias ( n = 11). None of the identified studies met EBI, EI, or ES criteria. Promising applicability was found for pharmacists prescribers, telePrEP, and mail-in testing. Delivery of PrEP services outside of the traditional care system by expanding providers of PrEP care (e.g. pharmacist prescribers), as well as the settings of PrEP care (i.e. telePrEP) and laboratory screening (i.e. mail-in testing) may increase PrEP access and care delivery.
Identifiants
pubmed: 37199602
doi: 10.1097/QAD.0000000000003601
pii: 00002030-202308010-00012
pmc: PMC10366650
mid: NIHMS1916054
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1593-1602Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
United Nations. Countries Commit to Action to End AIDS by 2030. 2023. Available at: https://www.un.org/en/academic-impact/countries-commit-action-end-aids-2030 [Accessed February 7, 2023].
Department of Health and Human Services. What is Ending the HIV Epidemic in the U.S.?. Available at: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview [Accessed February 7, 2023].
Centers for Disease Control and Prevention. PrEP for HIV Prevention in the U.S. Available at: https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/prep-for-hiv-prevention-in-the-us-factsheet.html .
AIDS Vaccine Advocacy Coalition (AVAC). Cumulative Number of PrEP Initiation. Available at: https://dataprepwatchorg/ . The Global PrEP Tracker; 2023.
Duby Z, Bunce B, Fowler C, Jonas K, Bergh K, Govindasamy D, et al. These girls have a chance to be the future generation of HIV negative: experiences of implementing a PrEP programme for adolescent girls and young women in South Africa . AIDS Behav 2023; 27:134–149.
Nabunya R, Karis VMS, Nakanwagi LJ, Mukisa P, Muwanguzi PA. Barriers and facilitators to oral PrEP uptake among high-risk men after HIV testing at workplaces in Uganda: a qualitative study . BMC Public Health 2023; 23:365.
Erdengasileng A, Tian S, Green SS, Naar S, He Z. Using Twitter data analysis to understand the perceptions, awareness, and barriers to the wide use of pre-exposure prophylaxis in the United States . Proceedings (IEEE Int Conf Bioinformatics Biomed) 2022; 2022:3000–3007.
Storholm ED, Ober AJ, Mizel ML, Matthews L, Sargent M, Todd I, et al. Primary care providers’ knowledge, attitudes, and beliefs about hiv pre-exposure prophylaxis (PrEP): informing network-based interventions . AIDS Educ Prev 2021; 33:325–344.
Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States . Am J Public Health 2019; 109:1216–1223.
World Health Organization. Second round of the national pulse survey on continuity of essential health services during the COVID-19 pandemic. Updated April 23rd, 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS-continuity-survey-2021.1 [Accessed April 14, 2023].
World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic. 2020. August 27th, 2020. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1 [Accessed April 14, 2023].
US Health Resources and Services Administration. What is telehealth? 2022. Updated June 29th, 2022. Available at: https://telehealth.hhs.gov/patients/understanding-telehealth/ [Accessed November 30, 2022].
Naitonal Institutes of Health. COVID-19 Testing. 2022. Updated August 11th, 2022. Available at: https://covid19.nih.gov/covid-19-topics/covid-19-testing [Accessed November 30, 2022].
The White House. Fact Sheet: President Biden Expands Efforts to Reqruite More Vaccinators. 2022. Updated March 12, 2021. Available at: https://www.whitehouse.gov/briefing-room/statements-releases/2021/03/12/fact-sheet-president-biden-expands-efforts-to-recruit-more-vaccinators/ [Accessed November 30, 2022].
US Health Resources and Services Administration. Coronavirus (COVID-19) Information. 2022. Available at: https://ryanwhite.hrsa.gov/grants/coronavirus [Accessed December 1, 2022].
US Centers for Disease Control and Prevention. HIV and COVID-19 Basics. Updated July 12th. Available at: https://www.cdc.gov/hiv/basics/covid-19.html [Accessed December 4, 2022].
Hoover KW, Zhu W, Gants, Delaney KP, Wiener J, Carnes N, et al. HIV services and outcomes during the COVID-19 pandemic — United States, 2019–2021 . MMWR Morb Mortal Wkly Rep 2022; 71:1505–1510.
Chasco EE, Hoth AB, Cho H, Shafer C, Siegler AJ, Ohl ME. Mixed-methods evaluation of the incorporation of home specimen self-collection kits for laboratory testing in a telehealth program for HIV preexposure prophylaxis . AIDS Behav 2021; 25:2463–2482.
Evans KN, Hassan R, Townes A, Buchacz K, Smith DK. The potential of telecommunication technology to address racial/ethnic disparities in HIV PrEP awareness, uptake, adherence, and persistence in care: a review . AIDS Behav 2022; 26:3878–3888.
Steward WT, Koester KA, Guzé MA, Delaney KP, Wiener J, Carnes N, et al. Practice transformations to optimize the delivery of HIV primary care in community healthcare settings in the United States: a program implementation study . PLoS Med 2020; 17:e1003079.
U.S. Centers for Disease Control and Prevention. HIV prevalence, 2008-2020 (COVID-19 Pandemic), Ages 13 years and older, All races/ethnicities, Both sexes, All transmission categories, United States. NCHHSTP AtlasPlus. Available at: https://gis.cdc.gov/grasp/nchhstpatlas/charts.html [Accessed November 22, 2022].
HIV.gov. Aging with HIV. 2022. Updated May 17th, 2021. Available at: https://www.hiv.gov/hiv-basics/living-well with-hiv/taking-care-of-yourself/aging-with-hiv [Accessed November 30, 2022].
The White House. National HIV/AIDS Strategy Federal Implementation Plan. Available at: https://files.hiv.gov/s3fs-public/2022-09/NHAS_Federal_Implementation_Plan.pdf [Accessed December 3, 2022].
Centers for Disease Control and Prevention. US Public Health Service: preexposure prophylaxis for the prevention of HIV infection in the United States − 2021 Update: a clinical practice guideline. 2021. November 23, 2022. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf [Accessed November 23, 2022].
Kamitani E, Mizuno Y, Collins C, DeLuca JB, Smith DK. Alternative PrEP care delivery models to improve PrEP care: systematic review . 2022; Available at: https://www.crd.york.ac.uk/PROSPERO/display_record.php ? RecordID=311747 [Accessed December 1, 2022].
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews . BMJ 2021; 372:n71.
Lyles CM, Crepaz N, Herbst JH, Kay LS. Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team . AIDS Educ Prev 2006; 18: (Suppl A): 21–31.
DeLuca JB, Mullins MM, Lyles CM, Crepaz N, Kay L, Thadiparthi S. Developing a comprehensive search strategy for evidence based systematic reviews . Evid Based Library Inform Pract 2008; 3:3–32.
Ngure K, Ortblad KF, Mogere P, Bardon AR, Thomas KK, Mangale D, et al. Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, noninferiority, implementation trial . Lancet HIV 2022; 9:e464–e473.
Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, Grangeiro A. Adapting to the COVID-19 pandemic: continuing HIV prevention services for adolescents through telemonitoring, Brazil . AIDS Behav 2020; 24:1994–1999.
Mata DA, Ramos MA, Bansal N, Khan R, Guille C, Di Angelantonio E, Sen S. Prevalence of depression and depressive symptoms among resident physicians: a systematic review and meta-analysis . JAMA 2015; 314:2373–2383.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses . Eur J Epidemiol 2010; 25:603–605.
Kamitani E, Johnson WD, Wichser ME, Adegbite AH, Mullins MM, Sipe TA. Growth in proportion and disparities of HIV PrEP use among key populations identified in the united states national goals: systematic review and meta-analysis of published surveys . J Acquir Immune Defic Syndr 2020; 84:379–386.
Kamitani E, Mizuno Y, Wichser ME, Adgbite AH, DeLuca JB, Higa D. Systematic review of correlational studies in predictors for HIV preexposure prophylaxis uptake in men who have sex with men. PROSPERO CRD42019112390. Available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019112390 .
U.S. Centers for Disease Control and Prevention. PrEP Best Practices Criteria. Updated January 21, 2022. Available at: https://www.cdc.gov/hiv/research/interventionresearch/compendium/prep/prep-best-practices.html [Accessed February 14, 2023].
Psihopaidas D, Cohen SM, West T, Avery L, Dempsey A, Brown K, et al. Implementation science and the Health Resources and Services Administration's Ryan White HIV/AIDS Program's work towards ending the HIV epidemic in the United States . PLoS Med 2020; 17:e1003128.
Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review . Front Public Health 2019; 7:64.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework . Am J Public Health 1999; 89:1322–1327.
Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition . Am J Public Health 2003; 93:1261–1267.
Glasgow RE, Klesges LM, Dzewaltowski DA, Bull SS, Estabrooks P. The future of health behavior change research: What is needed to improve translation of research into health promotion practice? . Ann Behav Med 2004; 27:3–12.
Dzewaltowski DA, Glasgow RE, Klesges LM, Estabrooks PA, Brock E. RE-AIM: evidence-based standards and a Web resource to improve translation of research into practice . Ann Behav Med 2004; 28:75–80.
Collins CB, Higa D, Taylor J, Wright C, Murray KH, Pitasi M, et al. Prioritization of evidence-based and evidence-informed interventions for retention in medical care for persons with HIV . AIDS Behav 2022; doi:10.1007/s10461-022-03958-1. [Epub ahead of print].
doi: 10.1007/s10461-022-03958-1.
O’Byrne P, Vandyk A, Orser L, Haines M. Nurse-led PrEP-RN clinic: a prospective cohort study exploring task-Shifting HIV prevention to public health nurses . BMJ Open 2021; 11:e040817.
Hoth AB, Shafer C, Dillon DB, Mayer R, Walton G, Ohl ME. Iowa TelePrEP: a public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state . Sex Transm Dis 2019; 46:507–512.
Lopez MI, Cocohoba J, Cohen SE, Trainor N, Levy MM, Dong BJ. Implementation of preexposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health . J Am Pharm Assoc (2003) 2020; 60:138–144.
Khosropour CM, Backus KV, Means AR, Beauchamps L, Johnson K, Golden MR, Mena L. A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation . AIDS Patient Care STDS 2020; 34:1–6.
Havens JP, Scarsi KK, Sayles H, Klepser DG, Swindells S, Bares SH. Acceptability and feasibility of a pharmacist-led HIV preexposure prophylaxis (PrEP) program in the Midwestern United States . Open Forum Infect Dis 2019; 6: doi:10.1093/ofid/ofz365.
doi: 10.1093/ofid/ofz365
Schmidt HA, McIver R, Houghton R, Selvey C, McNulty A, Varma R, et al. Nurse-led preexposure prophylaxis: a nontraditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial . Sex Health 2018; 15:595–597.
Kinuthia J, Pintye J, Abuna F, Mugwanya KK, Lagat H, Onyango D, et al. Preexposure prophylaxis uptake and early continuation among pregnant and postpartum women within maternal and child health clinics in Kenya: results from an implementation programme . Lancet HIV 2020; 7:e38–e48.
Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver preexposure prophylaxis to key populations by key populations in Thailand . Sex Health 2018; 15:542–555.
Refugio ON, Kimble MM, Silva CL, Lykens JE, Bannister C, Klausner JD. Brief report: PrEPTECH: a telehealth-based initiation program for hiv preexposure prophylaxis in young men of color who have sex with men. a pilot study of feasibility . J Acquir Immune Defic Syndr 2019; 80:40–45.
Stekler JD, McMahan V, Ballinger L, Viquez L, Swanson F, Stockton J, et al. HIV preexposure prophylaxis prescribing through telehealth . J Acquir Immune Defic Syndr 2018; 77:e40–e42.
Meyer JP, Price CR, Ye Y, Qin Y, Tracey D, Demidont AC, et al. A PrEP demonstration project using ehealth and community outreach to justice-involved cisgender women and their risk networks . AIDS Behav 2022; 26:3807–3817.
Player MS, Cooper NA, Perkins S, Diaz VA. Evaluation of a telemedicine pilot program for the provision of HIV preexposure prophylaxis in the Southeastern United States . AIDS Care 2022; 34:1499–1505.
Siegler AJ, Mayer KH, Liu AY, Patel RR, Ahlschlager LM, Kraft CS, et al. Developing and assessing the feasibility of a home-based preexposure prophylaxis monitoring and support program . Clin Infect Dis 2019; 68:501–504.
Gauthier TP, Toro M, Carrasquillo MZ, Corentin M, Lichtenberger P. A PrEP model incorporating clinical pharmacist encounters and antimicrobial stewardship program oversight may improve retention in care . Clin Infect Dis 2019; 68:347–349.
US Centers for Disease Control and Prevention. Advancing Team-Based Care Through Collaborative Practice Agreements: A Resource and Implementation Guide for Adding Pharmacists to the Care Team. U.S. Department of Health and Human Services; 2017. November 24th, 2022. Available at: https://www.cdc.gov/dhdsp/pubs/docs/CPA-Team-Based-Care.pdf [Accessed November 24, 2022].
Community Preventive Service Task Force. Heart Disease and Stroke Prevention Tailored Pharmacy-based Interventions to Improve Medication Adherence. 2022. Available at: https://www.thecommunityguide.org/findings/heart-disease-stroke-prevention-tailored-pharmacy-based-interventions-improve-medication-adherence.html [Accessed November 24, 2022].
US Centers for Disease Control and Prevention. Pharmacy: Collaborative Practice Agreements to Enable Collaborate Drug Therapy Management. 2022. Updated August 27th, 2021. Available at: https://www.cdc.gov/dhdsp/pubs/guides/best-practices/pharmacist-cdtm.htm [Accessed November 29, 2022].
Vu K. Pharmacist-Led Program Expands Access to PrEP in Indian Health Service. 2022. Available at: https://www.hiv.gov/blog/pharmacist-led-program-expands-access-prep-indian-health-service [Accessed November 22, 2022].
Nakambale HN, Roche SD, Mogere P, Omollo V, Kuo AP, Stergachis A, et al. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: an analysis of routine data . Front Reprod Health 2023; 5:1023568.
Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South . Curr HIV/AIDS Rep 2019; 16:259–269.
Hubach RD, Currin JM, Sanders CA, Durham AR, Kavanaugh KE, Wheeler DL, Croff JM. Barriers to access and adoption of pre-exposure prophylaxis for the prevention of HIV among men who have sex with men (MSM) in a relatively rural state . AIDS Educ Prev 2017; 29:315–329.
Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men . AIDS Behav 2018; 22:3566–3575.
Siegler AJ, Brock JB, Hurt CB, Ahlschlager L, Dominguez K, Kelley CF, et al. An electronic pre-exposure prophylaxis initiation and maintenance home care system for nonurban young men who have sex with men: protocol for a randomized controlled trial . JMIR Res Protoc 2019; 8:e13982.
Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of preexposure prophylaxis in the united states: a narrative review . Adv Ther 2020; 37:1778–1811.
Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, Zhang L. A global estimate of the acceptability of preexposure prophylaxis for HIV among men who have sex with men: a systematic review and meta-analysis . AIDS Behav 2018; 22:1063–1074.
The White House. National HIV/AIDS Strategy for the United States 2022−2025. Updated December 14th, 2021. Available at: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national-hiv-aids-strategy-2022-2025 [Accessed December 3, 2022].
Nurx. HIV PrEP. Available at: https://www.nurx.com/prep [Accessed March 3, 2023].
Hughes SD, Koester KA, Engesaeth E, Hawkins MV, Grant RM. Human enough: a qualitative study of client experience with internet-based access to preexposure prophylaxis . J Med Internet Res 2021; 23:e22650.
World Health Organization. Differentiated and simplified preexposure prophylaxis for HIV prevention: update to WHO implementation guidance. Technical Brief. 2022.
Tung EL, Thomas A, Eichner A, Shalit P. Implementation of a community pharmacy-based preexposure prophylaxis service: a novel model for preexposure prophylaxis care . Sex Health 2018; 15:556–561.